Fukoksantinin Sağlık Üzerindeki Etkileri

Yıl 2020, Cilt: 13 Sayı: 3, 93 - 102, 29.12.2020

Dilek Sivri Fatmagül Yur

Öz

Fukoksantin, yenilebilir kahverengi alglerde bol miktarda bulunan bir ksantofildir. Biyolojik etkilerini ortaya çıkaran eşsiz bir kimyasal yapıya sahiptir. Bu kimyasal yapı antienflamatuar etki ve güçlü bir antioksidan kapasite verir. Bu molekülün popülaritesinin artması, çoğunlukla fare çalışmaları ile tespit edilen antiobezite etkisinden kaynaklanmaktadır. Çalışmalar fukoksantinin kanser, obezite, diabetes mellitus ve karaciğer hastalığı gibi kronik hastalıkların önlenmesinin yanı sıra cilt koruyucu, antianjiyojenik, serebrovasküler koruyucu, kemik koruyucu, oküler koruyucu ve antimalaryal etkileri gibi sağlık açısından potansiyel faydaları olduğunu göstermiştir. Bu önemli rollerin ötesinde, hayvan çalışmaları fukoksantin takviyesinin olumsuz bir etkisi olmadığını göstermiştir. Bununla birlikte, insanlarda fukoksantin tüketiminin güvenliliği konusundaki araştırmalar eksiktir. Bu derlemenin amacı, fukoksantinin insan sağlığı üzerindeki ana etkilerini açıklamaktır.

Anahtar Kelimeler

fukoksantin, kahverengi algler, beslenme

Kaynakça

• Abidov M, Ramazanov Z, Seifulla R, Grachev S. The effects of Xanthigen in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat. Diabetes Obes. Metab. 2010; 12: 72–81.
• Afolayan AF, Bolton JJ, Lategan CA, Smith PJ, Beukes DR. Fucoxanthin, tetraprenylated toluquinone and toluhydroquinone metabolites from Sargassum heterophyllum inhibit the in vitro growth of the malaria parasite Plasmodium falciparum. Z. Naturforsch. 2008; 63: 848–852.
• Asai A, Sugawara T, Ono H, Nagao A. Biotransformation of fucoxanthinol into amarouciaxanthin A in mice and HepG2 cells: formation and cytotoxicity of fucoxanthin metabolites. Drug Metab Dispos. 2004; 32: 205-11.
• Asai A, Yonekura L, Nagao A. Low bioavailability of dietary epoxyxanthophylls in humans. Br. J. Nutr. 2008; 100: 273–77.
• Bae M, Kim MB, Park YK, Lee JY. Health benefits of fucoxanthin in the prevention of chronic diseases, BBA - Molecular and Cell Biology of Lipids. 2020;158618
• Beppu F, Niwano Y, Tsukui T, Hosokawa M, Miyashita K. Single and repeated oral dose toxicity study of fucoxanthin, a marine carotenoid, in mice. J. Toxicol. Sci. 2009; 34: 501–10.
• Beppu F, Hosokawa M, Niwano Y, Miyashita K. Effects of dietary fucoxanthin on cholesterol metabolism in diabetic/obese KK-Ay mice. Lipids Health Dis. 2012; 11: 112–19.
• Das SK, Hashimoto T, Kanazawa K. Growth inhibition of human hepatic carcinoma HepG2 cells by fucoxanthin is associated with down-regulation of cyclin D. Biochim. Biophys. Acta. 2008; 1780: 743–49. Das S, Ren RD, Hashimoto T, Kanazawa K. Fucoxanthin induces apoptosis in osteoclast-like cells differentiated from RAW264.7 cells. J. Agric. Food Chem. 2010; 58: 6090–095.
• Eom SH, Kim YM, Kim SK. Antimicrobial effect of phlorotannins from marine brown algae. Food Chem. Toxicol. 2012; 50(9): 3251-55.
• Farré G, Sanahuja G, Naqvi S, Bai C, Capell T, Zhu C, ve ark. Travel advice on the road to carotenoids in plants. Plant Sci. 2010; 179: 28–48.
• Gümüş R, İmik H. Etlik Piliç Rasyonuna İlave Edilen Fukoksantinin Bazı Kan Parametreleri Üzerine Etkisi, Türk Tarım – Gıda Bilim ve Teknoloji Dergisi. 2017; 5(11): 1379-82.
• Hashimoto T, Ozaki Y, Taminato M, Das SK, Mizuno M, Yoshimura K ve ark. The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice. Br. J. Nutr. 2009; 102: 242–8.
• Hashimoto T, Ozaki Y, Mizuno M, Yoshida M, Nishitani Y, Azuma T ve ark. Pharmacokinetics of fucoxanthinol in human plasma after the oral administration of kombu extract. The British journal of nutrition. 2012; 107: 1566-69.
• Haugan JA ve Liaaen-Jensen S. Algal Carotenoids 54. Carotenoids of Brown Algae (Phaeophyceae). Biochemical Systematics and Ecology. 1994; 22: 31-41.
• Heo SJ, Ko SC, Kang SM, Kang HS, Kim JP, Kim SH ve ark. Cytoprotective effect of fucoxanthin isolated from brown algae Sargassum siliquastrum against H2O2-induced cell damage. Eur Food Res Technol. 2008; 228:145–51.
• Heo SJ, Jeon YJ. Protective effect of fucoxanthin isolated from Sargassum siliquastrum on UV-B induced cell damage. J. Photochem. Photobiol. 2009; 95: 101–07.
• Heo SJ, Yoon WJ, Kim KN, Ahn GN, Kan SM, Kang DH ve ark. Evaluation of anti-inflammatory effect of fucoxanthin isolated from brown algae in lipopolysaccharide-stimulated RAW 264.7 macrophages. Food and chemical toxicology: an international journal published for the British Industrial Biological Research Association. 2010; 48: 2045-51. Hosokawa M, Kudo M, Maeda H, Kohno H, Tanaka T, Miyashita K. Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARγ ligand, troglitazone, on colon cancer cells. Biochim. Biophys. 2004; 1675: 113–19.
• Hosokawa M, Miyashita T, Nishikawa S, Emi S, Tsukui T, Beppu F ve ark. Fucoxanthin regulates adipocytokine mRNA expression in white adipose tissue of diabetic/obese KK-Ay mice. Arch. Biochem. Biophys. 2010; 504: 17–25.
• Hu T, Liu D, Chen Y, W, J, Wang S. Antioxidant activity of sulfated polysaccharide fractions extracted from Undaria pinnitafida in vitro. Int. J. Biol. Macromol. 2010; 46: 193–98.
• Iio K, Okada Y, Ishikura M. Single and 13-week oral toxicity study of fucoxanthin oil from microalgae in rats. Shokuhin Eiseigaku Zasshi. 2011; 52: 183–89.
• Ikeda K, Kitamura A, Machida H, Watanabe M, Negishi H, Hiraoka J ve ark. Effect of Undaria pinnatifida (Wakame) on the development of cerebrovascular diseases in stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. 2003; 30: 44–8.
• İlter I, Akyıl S, Koç M, Kaymak-Ertekin F. Alglerden Elde Edilen ve Gıdalarda Doğal Renklendirici Olarak Kullanılan Pigmentler ve Fonksiyonel Özellikleri. Türk Tarım – Gıda Bilim ve Teknoloji Dergisi. 2017; 5(12): 1508-15,
• Jeon SM, Kim HJ, Woo MN, Lee MK, Shin YC, Park YB ve ark. Fucoxanthin‐rich seaweed extract suppresses body weight gain and improves lipid metabolism in high‐fatfed C57BL/6J mice. Biotechnol. J. 2010; 5(9): 961-69.
• Jiang X, Wang G, Lin Q, Tang Z, Yan Q, Yu X. Fucoxanthin prevents lipopolysaccharide-induced depressive-like behavior in mice via AMPK- NF-kappaB pathway. Metab Brain Dis. 2019; 34: 431-42.
• Jung HA, Islam MN, Lee CM, Jeong HO, Chun, HY, Woo ve ark. Promising antidiabetic potential of fucoxanthin isolated from the edible brown algae Eisenia bicyclis and Undaria pinnatifida. Fish. Sci. 2012; 78: 1321–29.
• Kim KN, Heo SJ, Yoon WJ, Kang SM, Ahn G, Yi TH ve ark. Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-κB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages. Eur. J. Pharmacol. 2010; 649: 369–75. Kim SM, Jung YJ, Kwon ON, Cha KH, Um BH, Chung, D ve ark. A potential commercial source of fucoxanthin extracted from the microalga Phaeodactylum tricornutum. Appl Biochem Biotechnol. 2012; 166: 1843-55.
• Kotake-Nara E, Kushiro M, Zhang H, Sugawara T, Miyashita K, Nagao A. Carotenoids affect proliferation of human prostate cancer cells. J. Nutr. 2001; 131: 3303–06.
• Maeda H, Hosokawa M, Sashima T, Funayama K, Miyashita K. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochem. Biophys. Res. Commun. 2005; 332: 392–97.
• Maeda H, Hosokawa M, Sashima T, Takahashi N, Kawada T, Miyashita K. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells. Int. J. Mol. Med. 2006; 18: 147–52.
• Maeda H, Hosokawa M, Sashima T, Miyashita K. Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice. J. Agric. Food Chem. 2007(a); 55: 7701–06.
• Maeda H, Hosokawa M, Sashima T, Funayama K, Miyashita K. Effect of medium-chain triacylglycerols on anti-obesity effect of fucoxanthin. J. Oleo Sci. 2007(b); 56: 615–21.
• Maeda H, Tsukui T, Sashima T, Hosokawa M, Miyashita K. Seaweed carotenoid, fucoxanthin, as a multi-functional nutrient. Asia Pac. J. Clin. Nutr. 2008; 17: 196–9.
• Maeda H, Hosokawa M, Sashima T, Murakami-Funayama K, Miyashita K. Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model. Mol. Med. Rep. 2009; 2: 897–902.
• Matsumoto M, Hosokawa M, Matsukawa N, Hagio M, Shinoki A, Nishimukai M ve ark. Suppressive effects of the marine carotenoids, fucoxanthin and fucoxanthinol on triglyceride absorption in lymph duct-cannulated rats. Eur. J. Nutr. 2010; 49: 243–49.
• Miyashita K, Nishikawa S, Bepp, F, Tsukui T, Abe M, Hosokawa M. The allenic carotenoid fucoxanthin, a novel marine nutraceutical from brown seaweeds. J. Sci. Food Agr. 2011; 91(7): 1166-74.
• Miyashita K. Function of marine carotenoids. Forum Nutr. 2009; 61: 136–46.
• Moreau D, Tomasoni C, Jacquot C, Kaas R, Le Guedes R, Cadoret JP ve ark. Cultivated microalgae and the carotenoid fucoxanthin from Odontella aurita as potent anti-proliferative agents in bronchopulmonary and epithelial cell lines. Environ. Toxicol. Pharmcol. 2006; 22: 97–103.
• Nomura T, Kikuchi M, Kubodera A, Kawakami Y. Proton-donative antioxidant activity of fucoxanthin with 1,1-diphenyl-2-picrylhydrazyl (DPPH). Biochem. Mol. Biol. Int. 1997; 42: 361–70. Okada T, Mizuno Y, Sibayama S, Hosokawa M, Miyashita K. Antiobesity effects of Undaria lipid capsules prepared with scallop phospholipids. J. Food Sci. 2011; 76: H2–H6
• Park HJ, Lee MK, Park YB, Shin YC, Choi MS. Beneficial effects of Undaria pinnatifida ethanol extract on diet-induced-insulin resistance in C57BL/6J mice. Food Chem. Toxicol. 2011; 49: 727–33.
• Riccioni G, D’Orazio N, Franceschelli S, Speranza L. Marine carotenoids and cardiovascular risk markers. Mar. Drugs. 2011; 9: 1166–75.
• Sachindra NM, Sato E, Maeda H, Hosokawa M, Niwano Y, Kohno M ve ark. Radical scavenging and singlet oxygen qu enching activity of marine carotenoid fucoxanthin and its metabolites, Journal of agricultural and food chemistry. 2007; 55: 8516-22.
• Sangeetha RK, Bhaskar N, Baskaran V. Fucoxanthin restrains oxidative stress induced by retinol deficiency through modulation of Na+K+-ATPase and antioxidant enzyme activities in rats. Eur. J. Nutr. 2008; 47: 432–41.
• Sangeetha RK, Bhaskar N, Baskaran V. Comparative effects of β-carotene and fucoxanthin on retinol deficiency induced oxidative stress in rats. Mol. Cell. Biochem. 2009; 331: 59–67.
• Sangeetha RK, Bhaskar N, Divakar S, Baskaran V. Bioavailability and metabolism of fucoxanthin in rats: Structural characterization of metabolites by LC-MS (APCI). Mol. Cell. Biochem. 2010; 333: 299–310.
• Shete V ve Quadro L. Mammalian metabolism of beta-carotene: gaps in knowledge. Nutrients. 2013; 5: 4849-68.
• Shimoda H, Tanaka J, Shan SJ, Maoka T. Anti-pigmentary activity of fucoxanthin and its influence on skin mRNA expression of melanogenic molecules. J. Pharm. Pharmacol. 2010; 62: 1137–45.
• Shiratori K, Okgami K, Ilieva I, Jin XH, Koyama Y, Miyashita K ve ark. Effects of fucoxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Exp. Eye Res. 2005; 81: 422–28.
• Strand A, Herstad O, Liaaen-Jensen S. Fucoxanthin metabolites in egg yolks of laying hens. Comp. Biochem. Phys. A Mol. Integr. Physiol. 1998; 119: 963–74.
• Sugawara T, Baskaran V, Tsuzuki W, Nagao A. Brown algae fucoxanthin is hydrolyzed to fucoxanthinol during absorption by Caco-2 human intestinal cells and mice. The Journal of nutrition. 2002; 132: 946-51. Sugawara T, Matsubara K, Akagi R, Mori M, Hirata T. Antiangiogenic activity of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. J. Agric. Food Chem. 2006; 54: 9805–10.
• Synytsya A, Kim WJ, Kim SM, Pohl R, Synytsya A, Kvasnička F ve ark. Structure and antitumour activity of fucoidan isolated from sporophyll of Korean brown seaweed Undaria pinnatifida. Carbohyd. Polym. 2010; 81(1): 41-8.
• Takahashı K, Hosokawa M, Kasajıma H, Hatanaka K, Kudo K, Shımoyama N ve ark. Anticancer effects of fucoxanthin and fucoxanthinol on colorectal cancer cell lines and colorectal cancer tissues ONCOLOGY LETTERS. 2015; 10: 1463-67.
• Tan CP ve Hou YH. First evidence for the anti-inflammatory activity of fucoxanthin in high-fat-diet-induced obesity in mice and the antioxidant functions in PC12 cells. Inflammation. 2014; 37: 443-50.
• Thomas SE ve Johnson EJ. Xanthophylls. Adv Nutr. 2018; 9: 160.
• Tsukui T, Konno K, Hosokawa M, Maeda H, Sashima T, Miyashita K. Fucoxanthin and fucoxanthinol enhance the amount of docosahexaenoic acid in the liver of KKAy obese/diabetic mice. J. Agric. Food Chem. 2007; 55: 5025-29.
• Tsukui T, Baba N, Hosokawa M, Sashima T, Miyashita K. Enhancement of hepatic docosahexaenoic acid and arachidonic acid contents in C57BL/6J mice by dietary fucoxanthin. Fish. Sci. 2009; 75: 261–63.
• Urikura, I, Sugawara T, Hirata T. Protective effect of fucoxanthin against UVB-induced skin photoaging in hairless mice. Biosci. Biotechnol. Biochem. 2011; 75: 757–60.
• Wellen KE ve Hotamisligil GS Inflammation, stress, and diabetes. J. Clin. Invest. 2005; 115: 1111–19.
• Woo MN, Jeon SM, Kim HJ, Le MK, Shin SK, Shin YC ve ark. Fucoxanthin supplementation improves plasma and hepatic lipid metabolism and blood glucose concentration in high-fat fed C57BL/6N mice. Chem. Biol. Interact. 2010; 186: 316–22.
• Xia S, Wang K, Wan L, Li A, Hu Q, Zhang C. Production, characterization, and antioxidant activity of fucoxanthin from the marine diatom Odontella aurita. Marine drugs. 2013; 11: 2667-81.
• Yan X, Chuda Y, Suzuki M, Nagata T. Fucoxanthin as the major antioxidant in Hijikia fusiformis, a common edible seaweed. Biosci. Biotechnol. Biochem. 1999; 63: 605–7.
• Yasuda M, Ohzeki Y, Shimizu S, Naito S, Ohtsuru A, Yamamoto T ve ark. Stimulation of in vitro angiogenesis by hydrogen peroxide and the relation with ETS-1 in endothelial cells. Life Sci. 1999; 64: 249–58.
• Yim MJ, Hosokawa M, Mizushina Y, Yoshida H, Saito Y, Miyashita K. Suppressive effects of amarouciaxanthin A on 3T3-L1 adipocyte differentiation through down-regulation of PPARγ and C/EBPα mRNA expression. J. Agric. Food Chem. 2011; 59: 1646–52.
• Yu RX, Hu XM, Xu S-Q, Jiang ZJ, Yang W. Effects of fucoxanthin on proliferation and apoptosis in human gastric adenocarcinoma MGC-803 cells via JAK/STAT signal pathway. Eur. J. Pharmacol. 2011; 657: 10–19.
• Zhao D, Kim SM, Pan CH, Chung D. Effects of heating, aerial exposure and illumination on stability of fucoxanthin in canola oil. Food chemistry. 2014; 14(5): 505-13.